ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Personal Emergency Response Attendant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,822Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 43

$354K Total Retail Price of All Prescriptions

Rank: 4 out of 43

397 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 8,025 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 527 456 1 1
LOSARTAN-HYDROCHLOROTHIAZIDE 518 437 2 11
OMEPRAZOLE 379 310 3 7
PENTOXIFYLLINE 336 281 4 46
TRAMADOL HCL-ACETAMINOPHEN 296 258 5 6
LEVOTHYROXINE SODIUM 252 231 6 13
ENALAPRIL MALEATE 249 213 7 4
GLIPIZIDE 236 202 8 18
METFORMIN HCL 217 187 9 3
AMLODIPINE BESYLATE 213 159 10 8
GABAPENTIN 203 161 11 5
FUROSEMIDE 202 180 12 12
RANITIDINE HCL 193 154 13 2
METOPROLOL TARTRATE 172 144 14 26
ZOLPIDEM TARTRATE 162 125 15 22
SERTRALINE HCL 152 136 16 32
CIPROFLOXACIN HCL 144 112 17 19
ATENOLOL 142 125 18 10
KETOCONAZOLE 129 75 19 44
SYNTHROID 115 95 20 15
LOSARTAN POTASSIUM 110 99 21 9
TRAMADOL HCL 106 70 22 39
MECLIZINE HCL 89 85 23 42
LISINOPRIL 85 56 24 17
CARVEDILOL 79 73 25 33
VERAPAMIL ER 76 72 26 73
SINGULAIR 75 64 27 56
ISOSORBIDE MONONITRATE ER 75 75 27 28
DICLOFENAC POTASSIUM 70 53 29 14
HYDROCHLOROTHIAZIDE 69 61 30 16
OXYCODONE-ACETAMINOPHEN 67 26 S2 31 31
DONEPEZIL HCL 67 67 31 45
ZETIA 67 52 31 120
CLOPIDOGREL 66 66 34 48
NABUMETONE 66 48 34 21
PLAVIX 66 65 34 52
ASPIRIN EC 63 50 37 36
CYMBALTA 62 57 38 53
PAROXETINE HCL 59 44 39 54
LYRICA 59 50 39 74
INSULIN SYRINGE 55 39 41 66
HUMALOG MIX 75-25 54 47 42 130
DIGOXIN 52 39 43 68
TAMSULOSIN HCL 52 49 43 30
MEGESTROL ACETATE 51 50 R 45 63
ALENDRONATE SODIUM 51 51 45 20
NAMENDA 51 51 45 92
WARFARIN SODIUM 50 35 48 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.